News on Drug Safety Evaluation Consulating Incorporated from BioPortfolio.com http://www.BioPortfolio.com Consolidated Drug Safety Evaluation Consulating Incorporated news from BioPortfolio.com Wed, 10 Feb 2010 15:09:20 GMT en Golimumab shows robust effect for inhibiting arthritic joint damagehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031904&HITNO=0&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031904&THISHREF=http://c.moreover.com/click/here.pl%3fz2534421575%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031904&HITNO=0&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031904&THISHREF=http://c.moreover.com/click/here.pl%3fz2534421575%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comModern Medicine: Evaluation and Management of Cardiac Safety Using the Electrocardiogram in Oncology Clinical Trials: Focus onhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030938&HITNO=1&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030938&THISHREF=http://c.moreover.com/click/here.pl%3fz2533901883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030938&HITNO=1&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030938&THISHREF=http://c.moreover.com/click/here.pl%3fz2533901883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNature: AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026830&HITNO=2&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026830&THISHREF=http://c.moreover.com/click/here.pl%3fz2531375529%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026830&HITNO=2&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026830&THISHREF=http://c.moreover.com/click/here.pl%3fz2531375529%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: FDA Will Encourage Voluntary Reporting of LDT Adverse Events to MedWatch Systemhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023294&HITNO=3&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023294&THISHREF=http://c.moreover.com/click/here.pl%3fz2528151271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023294&HITNO=3&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023294&THISHREF=http://c.moreover.com/click/here.pl%3fz2528151271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenomeWeb: AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013023&HITNO=4&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013023&THISHREF=http://c.moreover.com/click/here.pl%3fz2523587061%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013023&HITNO=4&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013023&THISHREF=http://c.moreover.com/click/here.pl%3fz2523587061%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013217&HITNO=5&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013217&THISHREF=http://c.moreover.com/click/here.pl%3fz2523656130%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013217&HITNO=5&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013217&THISHREF=http://c.moreover.com/click/here.pl%3fz2523656130%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013107&HITNO=6&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013107&THISHREF=http://c.moreover.com/click/here.pl%3fz2523611464%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013107&HITNO=6&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013107&THISHREF=http://c.moreover.com/click/here.pl%3fz2523611464%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013052&HITNO=7&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013052&THISHREF=http://c.moreover.com/click/here.pl%3fz2523594648%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013052&HITNO=7&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013052&THISHREF=http://c.moreover.com/click/here.pl%3fz2523594648%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscularhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013056&HITNO=8&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013056&THISHREF=http://c.moreover.com/click/here.pl%3fz2523596154%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013056&HITNO=8&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013056&THISHREF=http://c.moreover.com/click/here.pl%3fz2523596154%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInterest!ALERT: AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013598&HITNO=9&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013598&THISHREF=http://c.moreover.com/click/here.pl%3fz2523771354%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013598&HITNO=9&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013598&THISHREF=http://c.moreover.com/click/here.pl%3fz2523771354%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: AVI BioPharma GLP Safety Pharmacology and Genotoxicityhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013058&HITNO=10&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013058&THISHREF=http://c.moreover.com/click/here.pl%3fz2523596632%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013058&HITNO=10&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013058&THISHREF=http://c.moreover.com/click/here.pl%3fz2523596632%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire via MSN Money: AVI BioPharma (AVII) Announces GLP Results for Duchenne MD Treatment AVI-4658http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013563&HITNO=11&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013563&THISHREF=http://c.moreover.com/click/here.pl%3fz2523758641%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013563&HITNO=11&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013563&THISHREF=http://c.moreover.com/click/here.pl%3fz2523758641%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: IEA Awarded Contract by the U.S. Nuclear Regulatory Commission (NRC)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017221&HITNO=12&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017221&THISHREF=http://c.moreover.com/click/here.pl%3fz2525043200%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017221&HITNO=12&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017221&THISHREF=http://c.moreover.com/click/here.pl%3fz2525043200%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: FDA's in vitro diagnostics office to house radiology devices unithttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999789&HITNO=13&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999789&THISHREF=http://c.moreover.com/click/here.pl%3fz2517651445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999789&HITNO=13&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999789&THISHREF=http://c.moreover.com/click/here.pl%3fz2517651445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Addendum to ICH S6: Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals S6(R1)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000941&HITNO=14&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000941&THISHREF=http://c.moreover.com/click/here.pl%3fz2518248329%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000941&HITNO=14&MSIZE=73&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Drug%20Safety%20Evaluation%20Consulating%20Incorporated&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000941&THISHREF=http://c.moreover.com/click/here.pl%3fz2518248329%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBIO: